BIOCEPT INC - 09072V105
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GARRISON BRADFORD & ASSOCIATES INC | History | Reduced | 153,400 | 923 | 0.86% | 1.11% | 1 | -3,000 | -1.92% | Q2 2014 | Jul 14, 2014 |
| PERKINS CAPITAL MANAGEMENT INC | History | No change | 89,450 | 657 | 0.46% | 0.46% | 2 | 0 | 0.0% | Q1 2014 | May 07, 2014 |
| Verition Fund Management LLC | History | No change | 80,483 | 591 | 0.09% | 0.09% | 3 | 0 | 0.0% | Q1 2014 | May 14, 2014 |
| LMR Partners LLP | History | Reduced | 43,852 | 264 | 0.02% | 0.09% | 4 | -47,116 | -51.79% | Q2 2014 | Jul 10, 2014 |
| VANGUARD GROUP INC | History | Added to | 29,465 | 177 | 0.0% | 0.0% | 5 | +1,600 | 5.74% | Q2 2014 | Aug 11, 2014 |
| Camelot Portfolios, LLC | History | New | 10,000 | 60 | 0.04% | — | 6 | +10,000 | New | Q2 2014 | Aug 07, 2014 |
| UBS AG | History | No change | 707 | 5 | 0.0% | 0.0% | 7 | 0 | 0.0% | Q1 2014 | May 16, 2014 |
| MORGAN STANLEY | History | No change | 208 | 2 | 0.0% | 0.0% | 8 | 0 | 0.0% | Q1 2014 | May 13, 2014 |
| WELLS FARGO & COMPANY/MN | History | No change | 125 | 1 | 0.0% | 0.0% | 9 | 0 | 0.0% | Q1 2014 | May 15, 2014 |
| CITIGROUP INC | History | No change | 8 | 0 | — | — | — | 0 | 0.0% | Q1 2014 | May 15, 2014 |